Nitric oxide inhalation in pulmonary hypertension and severe respiratory failure

Citation
M. Max et R. Rossaint, Nitric oxide inhalation in pulmonary hypertension and severe respiratory failure, CURR OPIN C, 14(5), 1999, pp. 432-436
Citations number
39
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
CURRENT OPINION IN CARDIOLOGY
ISSN journal
02684705 → ACNP
Volume
14
Issue
5
Year of publication
1999
Pages
432 - 436
Database
ISI
SICI code
0268-4705(199909)14:5<432:NOIIPH>2.0.ZU;2-E
Abstract
Inhalation of nitric oxide (NO) can cause selective pulmonary vasodilation in aerated lung regions; thus, it may be of benefit in the treatment of var ious forms of pulmonary hypertension and respiratory distress due to a mism atch of pulmonary ventilation and perfusion, The specific characteristics o f inhaled NO exclude long-term treatment, but NO has been successfully used as a test substance to screen patients for response to oral vasodilators. Furthermore, inhalation of NO has been shown to improve gas exchange and ri ght ventricular performance and to reduce the need for other, more invasive therapies in various settings of acute pulmonary hypertension, However, th e improvement of arterial oxygenation seen in patients with the acute respi ratory distress syndrome does not result in increased survival, questioning the future importance of inhaled NO in the treatment of this pulmonary dis order. Curr Opin Cardiol 1999, 14:432-436 (C) 1999 Lippincott Williams & Wi lkins, Inc.